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The purpose of this document is to describe
guidelines for disclosure of possible conflicts of
interest for (1) SVS/ISCVS executive councils,
committee members, and appointees and (2) orga-
nized educational meetings. We review the back-
ground principles and suggest approaches that will
be helpful in recognizing, avoiding, and dealing with
situations that may represent a conflict of interest.
BACKGROUND
Why important
Issues of conflict of interest have assumed greater
focus in maintaining trust. With the establishment
of these standards for disclosure of possible conflicts
of interest, the overall goal is to protect the integri-
ty of the decision-making processes of the councils
and their committees; to assure the members that
the selection, presentation, and publication of scien-
tific work are not biased by competing financial
issues; to maintain the public confidence in the
Societies; and to protect the stature of the Societies. 
Because decisions by the councils and their com-
mittees and the “integrity” of a presentation at our
meetings may be biased by a member’s financial or pro-
fessional interests, it is appropriate to consider how to
minimize the influence of real or perceived self-interest.
Definition
Conflict of interest is a circumstance or situation
that is present if an individual’s primary responsibility
(eg, obligations, actions, views, judgment, or deci-
sions) might be influenced by secondary factors (eg,
the potential for personal financial profit, profession-
al competition, academic gain, or personal opinions
or biases). There is nothing wrong with having sec-
ondary interests, and indeed, it is often desirable to
select individuals for appointments or for presenta-
tions who have broad interests or relationships.
However, problems arise if the secondary interests
influence or appear to influence the primary responsi-
bility (eg, the obligation for unbiased patient care,
the integrity of research, or the importance of making
impartial decisions on behalf of a society).
For pragmatic reasons, primarily financial con-
flicts of interest are considered. However, it is
acknowledged that individuals may also be influ-
enced by nonfinancial factors such as personal bias. 
Is conflict of interest present?
Although it may not be possible to precisely iden-
tify conflict of interest, the following factors are
important to consider in judging if conflict of interest
is present: (1) it applies to a specific circumstance or
situation; (2) conflict of interest exists in relationship
to a role and the duties and moral requirements
attached to the role; (3) the greater the potential for
personal gain, the greater the concern about the sig-
nificance of the conflict of interest; and (4) the greater
the potential harm, the greater the concern.1 Because
absolute rules are not possible, an appropriate test of
potential conflict is to evaluate whether a decision or
actions would be considered to be trustworthy and
credible if the potential conflict were made known.
Seriousness of the conflict
The severity of a conflict depends on multiple
factors. The factors include (1) the importance of
the individual’s primary interest (eg, patient’s wel-
fare or integrity of research is paramount and should
not be weakened); (2) the chance that the individ-
ual’s obligation, action, views, judgment, or deci-
sions will be influenced by secondary factors; and (3)
the seriousness of the harm that might result if con-
flict of interest is present.
Existing approaches to providing a solution
Law and ethics interact and usually are mutually
reinforcing; they are briefly discussed below.1
Law. The conduct of lawyers in the lawyer/client
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relationship, security traders, agents, and others is
governed by a large body of legal opinions and disci-
plinary rulings by courts. In law, the principles of
conflict of interest grew out of fiduciary law, specifi-
cally the law of trusts where trustees are required to
act solely in the interests of the beneficiary. Applicable
common law principles could include those related to
fiduciary duty, informed consent, negligence, bad
faith, kickbacks, and fraud. State statutes apply to
officers of nonprofit corporations and to a corporate
official’s conflicts of interest.
Bioethics. Modern bioethics is based on the prin-
ciples of beneficence (to do good), nonmaleficence
(to do no harm), justice, and patient autonomy.
Because of the imbalance of power between physicians
and patients, preserving justice is an altruistic goal and
a standard against which our efforts in dealing with
conflicts of interest with regard to any patient matter
can be measured. This could relate to the develop-
ment of practice guidelines, the appointment of com-
mittees, and the presentation of scientific work.
Professional standards. Although many societies
have codes of ethics, few have specific standards relat-
ed to conflicts of interest or procedures for evaluating
potential conflicts of interest or defined sanctions and
appeal mechanisms for violations. Only in 1986 did
the American Medical Association advise physicians to
resolve all conflicts of interest in favor of patients, and
more recently, the American Heart Association has
published Conflict of Interest Standards.2
POLICY FOR SVS/ISCVS
Policy for dealing with conflict of interest in
administrative matters
Principle. All council members, committee mem-
bers, the editors of the Journal of Vascular Surgery, and
other appointees or employees of the SVS/ISCVS shall
avoid conflict of interest between the well-being of the
Societies and their own personal financial gain in ful-
filling their obligations, making decisions, and express-
ing their views on behalf of the Societies.
Two approaches. Two approaches are suggested.
Voluntary exemption. The Societies encourage each
individual to exercise the character and good judgment
to be aware that self-interests may unintentionally bias
his or her decisions or actions and to voluntarily exempt
himself or herself from discussion of these issues. At
each committee meeting, the chair will remind the
members of the importance of declaring any potential
conflict of interest and note that they must exempt
themselves from discussion on the agenda item.
Regulations regarding disclosure. The following
regulations are not a substitute for openness and
integrity but will be useful in managing complex sit-
uations that pose a conflict of interest. With regard
to regulations, the following comments are of note.
First, in the development of an approach to pre-
vent a circumstance where there is the perception of a
conflict of interest in relationship to an individual car-
rying out his or her duties, it must be recognized that
there may be disagreement on the baseline standard of
behavior beyond which it would be considered unsat-
isfactory. Second, because of the complexity of the
ethical situation, categorical rules are not possible:
only principles can be established, and they must be
applied with discretion. Third, the rules are based on
the assumption that disclosure of potential conflicts
will identify potential problems. Note that disclosure
does not provide the solution for addressing the
potential problem. If the conflict is significant, the
solutions include either abstention from involvement
if the individual has substantial secondary interests or
divestiture of the secondary interests.
Financial conflicts that should be disclosed.
Because of the influence of their positions, council
members, committee members, and editors must be
particularly sensitive to the issue of actual or
perceived conflict of interest. Financial conflict of
interest may be present if an individual (or family
member) has any of the following relationships with
biomedical companies, device manufacturers, or
pharmaceutical companies:
• officer, board member, trustee, owner or employ-
ee of a company
• owner of stock, stock options, or a bond holder 
(including immediate family)
• paid consultancy, scientific advisory committee 
membership, or lecturer for a company in the last 
12 months (note: disclosure is not required for an 
honorarium paid by a university, hospital, or med-
ical society that extends the invitation for a lecture 
and has received unrestricted funding) 
• investigator for the company including holding 
research grants from the company
• holder of patent 
As noted above, there is nothing wrong if an
individual has a major financial interest in a compa-
ny. However, it is not appropriate for the individual
with a financial interest in a company (or a compet-
itive company) to influence the Societies’ position
on an issue that might have an impact on the com-
pany or a competitive company.
Procedure for avoiding conflict of interest,
disclosure, and actions. On an annual basis, mem-
bers of the SVS/ISCVS Council, members of com-
mittees, and editors of the Journal of Vascular
Surgery will complete a conflict of interest form and
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submit it to the executive director. The form will ask
individuals to list their possible conflicts of interest.
During the year, the individual should voluntarily
update the information as necessary. The compiled
disclosures will be available to the chairs of the
Council meetings and chairs of the committee meet-
ings on a need-to-know basis. 
At each Council or committee meeting, the chair
will request that all members disclose if they have
any potential conflict of interest with items on the
agenda. Those with a conflict of interest will not par-
ticipate in the discussion or vote on the matter. It
will usually be appropriate for the individual to leave
the room. The minutes will reflect the action taken. 
If there is a question on an individual’s potential
conflict of interest, the chair will make the decision.
If the chair is perceived to have a conflict of interest
in relationship to an agenda item, the decision will
be made by a vote of all members present. Members
should refrain from accepting committee responsi-
bilities if they have or are likely to have a financial
relationship that might impair or appear to impair
the member’s objectivity.
In the case of editors of the Journal of Vascular
Surgery, full disclosure of potential conflicts of interest
is required before appointment, and annual disclosure
is required. Because of their position, the editors must
be particularly sensitive to the issue of actual or per-
ceived conflicts of interest. It may be necessary for the
individuals to divest themselves of certain investments
or holdings or place them in a blind trust.
Sanctions. If an individual willfully fails to fully
disclose the information requested, he or she will be
disqualified from participation in administrative
decisions of the SVS/ISCVS for a period of not less
than 12 months.
Policy for dealing with conflict of interest in the
educational program
Principle. At SVS/ISCVS–sponsored programs,
the audience should be informed of the author’s
potential conflict of interest, which might have
unconsciously biased decisions in the design, imple-
mentation, analysis, or discussion of the research.
Through disclosure, competitive interests are made
transparent; consequently, the readers can assess the
magnitude of the competition and add this to their
overall interpretation of the published work.
Organization of educational programs. The fol-
lowing comments relate to educational programs and
not to specific training in the use of a medical device: 
• Educational programs sponsored by the SVS/
ISCVS must be free from industrial interference 
and influence. Specifically, the Societies must have 
full control over the scientific content of any pro-
gram and selection of the presenters. Explicit 
endorsement of a sponsor’s product must be 
avoided. 
• The individuals organizing a symposium that is 
sponsored by the SVS/ISCVS, but funded by a 
company, should not have a financial relationship 
with the company.
• Expenses and honoraria for specific individual 
speakers at SVS/ISCVS–sponsored meetings can-
not be supported by a specific company.
• Negotiations for space at SVS/ISCVS–sponsored 
meetings should not be influenced by industry 
sponsorship. 
Presenters’ disclosure. For papers selected for
presentation, the senior author is responsible for
completing a conflict of interest statement on behalf
of all authors. Similarly, invited presenters and dis-
cussants will complete a conflict of interest state-
ment. The Societies require that the financial rela-
tions between presenters and companies be disclosed
to the audience.3-5
Sanction. If an individual willfully fails to fully
disclose the information requested, he or she will be
disqualified from participation in educational pro-
grams sponsored by the SVS/ISCVS for a period of
not less than 12 months.
Appeal on decision related to conflict of interest 
As necessary, a committee consisting of the past
two presidents from each Society (the chair will be
decided by mutual agreement by the four individu-
als) will meet to address questions of conflict of
interest. As necessary, it will review and suggest solu-
tions to conflict of interest of potential appointees to
Council, committees, and editorial positions on the
Journal of Vascular Surgery and will answer an indi-
vidual’s complaints or requests for appeal on a deci-
sion related to conflict of interest. This committee’s
decision may be appealed to the Joint Council. 
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